NCT04649411View on ClinicalTrials.gov

Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions
Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Interventions
DRUG

ferric citrate

oral tablets

DRUG

standard of care

administered per the approved label and at the Investigator's discretion

Sponsors
All Listed Sponsors
lead

Keryx Biopharmaceuticals

INDUSTRY